top of page
The latest from NuvOx
Search
Nov 2, 2023
NuvOx Announces Contract to Support NOVEL Trial
Tucson, AZ, USA, October 31, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic...
Oct 2, 2023
NuvOx Therapeutics Wins Most Fundable Company by Pepperdine Graziadio Business School
Tucson, AZ, September 28th, 2023 NuvOx Therapeutics (“NuvOx”) is delighted to announce that it achieved the Gold Level recognition on the...
Sep 25, 2023
NuvOx Closed Oversubscribed Convertible Notes
Tucson, AZ, September 18th, 2023 NuvOx Therapeutics (“NuvOx”) announced that it has closed an oversubscribed convertible notes round,...
Aug 30, 2023
NuvOx Announces Publication of Research Article in Cancer Research Communication
Tucson, AZ, August 28th, 2023 NuvOx Pharma announced publication of a research article, “Dodecafluoropentane Emulsion as a...
Aug 14, 2023
NuvOx Announces BARDA Partnership for a Phase Ib ARDS/COVID Trial in Canada
Tucson, AZ, August 4th, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to...
bottom of page